Free Trial
NASDAQ:ACIU

AC Immune (ACIU) Stock Price, News & Analysis

AC Immune logo
$2.06 +0.04 (+1.98%)
Closing price 02:31 PM Eastern
Extended Trading
$2.06 0.00 (0.00%)
As of 04:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About AC Immune Stock (NASDAQ:ACIU)

Key Stats

Today's Range
$1.96
$2.07
50-Day Range
$1.53
$2.20
52-Week Range
$1.43
$4.26
Volume
113,290 shs
Average Volume
145,325 shs
Market Capitalization
$206.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Buy

Company Overview

AC Immune Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

ACIU MarketRank™: 

AC Immune scored higher than 53% of companies evaluated by MarketBeat, and ranked 551st out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    AC Immune has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    AC Immune has only been the subject of 1 research reports in the past 90 days.

  • Read more about AC Immune's stock forecast and price target.
  • Earnings Growth

    Earnings for AC Immune are expected to grow in the coming year, from ($0.62) to ($0.07) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of AC Immune is -3.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of AC Immune is -3.55, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    AC Immune has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about AC Immune's valuation and earnings.
  • Percentage of Shares Shorted

    2.23% of the float of AC Immune has been sold short.
  • Short Interest Ratio / Days to Cover

    AC Immune has a short interest ratio ("days to cover") of 9.2.
  • Change versus previous month

    Short interest in AC Immune has recently decreased by 2.16%, indicating that investor sentiment is improving.
  • Dividend Yield

    AC Immune does not currently pay a dividend.

  • Dividend Growth

    AC Immune does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.23% of the float of AC Immune has been sold short.
  • Short Interest Ratio / Days to Cover

    AC Immune has a short interest ratio ("days to cover") of 9.2.
  • Change versus previous month

    Short interest in AC Immune has recently decreased by 2.16%, indicating that investor sentiment is improving.
  • News Sentiment

    AC Immune has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for AC Immune this week, compared to 1 article on an average week.
  • Search Interest

    4 people have searched for ACIU on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, AC Immune insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of AC Immune is held by insiders.

  • Percentage Held by Institutions

    51.36% of the stock of AC Immune is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about AC Immune's insider trading history.
Receive ACIU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for AC Immune and its competitors with MarketBeat's FREE daily newsletter.

ACIU Stock News Headlines

ACIU AC Immune SA - Seeking Alpha
AC Immune SA (ACIU) - Yahoo Finance
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…
See More Headlines

ACIU Stock Analysis - Frequently Asked Questions

AC Immune's stock was trading at $2.70 on January 1st, 2025. Since then, ACIU stock has decreased by 23.7% and is now trading at $2.06.

AC Immune (NASDAQ:ACIU) announced its quarterly earnings results on Wednesday, April, 30th. The company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.01. The company earned $1.12 million during the quarter, compared to analysts' expectations of $1.99 million. AC Immune had a negative trailing twelve-month return on equity of 44.60% and a negative net margin of 177.79%.

AC Immune (ACIU) raised $55 million in an IPO on Friday, September 23rd 2016. The company issued 4,600,000 shares at $11.00-$13.00 per share. Credit Suisse, Jefferies and Leerink Partners acted as the underwriters for the IPO.

Shares of ACIU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that AC Immune investors own include Meta Platforms (META), NVIDIA (NVDA), Corbus Pharmaceuticals (CRBP), Sorrento Therapeutics (SRNE), Tesla (TSLA), Advanced Micro Devices (AMD) and Canopy Growth (CGC).

Company Calendar

Last Earnings
4/30/2025
Today
7/03/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACIU
Employees
140
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$12.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+482.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$57.83 million
Net Margins
-177.79%
Pretax Margin
-179.67%

Debt

Sales & Book Value

Annual Sales
$31.02 million
Price / Cash Flow
N/A
Book Value
$1.29 per share
Price / Book
1.60

Miscellaneous

Free Float
95,791,000
Market Cap
$206.84 million
Optionable
Optionable
Beta
1.62
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:ACIU) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners